South Korea
GenScript ProBio Congratulates Selecxine's IND Clearance from MFDS
GenScript ProBio extended congratulations on this. Since December 2019, GenScript ProBio has joined the strategic collaboration with Selecxine for the...
December 07, 2022 | News
Chemotherapy may be completed within 8 days with two doses of Polytaxel, an innovative anticancer drug from South Korea's biotech firm
Polytaxel, a novel pain-free anticancer drug, may not require break periods A new standard of care, more convenient than docetaxel, is suggest...
November 28, 2022 | News
Everest Medicines Announces Major Regulatory Updates in Taiwan and South Korea
-- Taiwan Food and Drug Administration grants Accelerated Approval Designation (AAD) to Nefecon -- -- Ministry of Food and Drug Safety in S...
November 28, 2022 | News
Hugel's 'Letybo' First in Korea to Obtain Marketing Approval from Australia
Obtained marketing approval on the 23rd (local time) from the Therapeutic Goods Administration (TGA) of Australia for the indication of gl...
November 25, 2022 | News
Lunit Partners with CARPL.ai to Accelerate AI-Powered Medical Imaging Across Major Overseas Channels
Lunit signed a global distribution agreement to provide its AI-based radiology solutions for clinical use via CARPL.ai's platform The partnership will d...
November 24, 2022 | News
Lunit Becomes the First Medical Software Company in Asia-Pacific to Become MDR CE and UKCA Certified
Lunit becomes first software as a medical device (SaMD) company in APAC to become MDR CE and UKCA certified MDR and UKCA certifications are requ...
November 22, 2022 | News
MEDICOX Signs Contract with ORAMED to Distribute Oral Insulin in South Korea
MEDICOX secures distribution right for ORAMED's oral insulin in South Korea after phase 3 of FDA approval- Contract scale up to 18...
November 21, 2022 | News
Lunit to Supply AI Platform to Australia's BreastScreen NSW Machine Reading Project
Lunit's INSIGHT MMG solution has been selected for mammogram screening in Australia's BreastScreen NSW's AI evaluation and clinical integration...
November 17, 2022 | News
Standigm Synthetic Research Center successfully accelerates drug discovery in its first year
Standigm, the workflow AI-driven drug discovery company, today announced the celebration of its Synthetic Research Center's first year. In the last 12 mont...
November 17, 2022 | News
Daewoong and HitGen Announce Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery
HitGen will apply its DNA-encoded library (DEL) technology platform centered around the design, synthesis and screening of thousands of DELs that collectiv...
November 14, 2022 | News
Lunit Highlights the Effectiveness of AI in Acceleration of Immunotherapy Research
Lunit to present three abstracts featuring Lunit SCOPE IO, the company's AI biomarker for immune phenotyping. Lunit's presentations this year will highl...
November 08, 2022 | News
Brexogen's Exosome Therapy for Atopic Dermatitis, 'BRE-AD01' Accepted for Phase 1 Clinical Trials by US FDA
The US FDA granted the initiation of the phase 1 clinical trial of 'BRE-AD01', an exosome- based therapy for atopic dermatitis. 'BRE-AD01' is being develop...
November 07, 2022 | News
Most Read
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
